The mergers and acquisitions market in addictions and substance abuse is at an inflection point. Demand is beginning to shift from a largely high-end, out-of-network residential focus, to value-oriented, in-network and community-based programs that may be short on sex appeal, but long on cost, growth, and stability appeal.
We are already seeing this subtle shift in the recent swell of transaction activity involving medication-assisted treatment providers. In this session, Dexter Braff will discuss why the substance abuse deal climate is in transition and how this may reshape investment strategies, demand, and valuation in addictions M&A over the next 12 to 36 months.
- Discuss how the trajectory in addictions and substance abuse M&A has recently played out
- Describe the factors that are reshaping the acquisitions market
- Relate how changes will impact acquisition candidate supply and demand, deal flow and valuations over the next 12 to 26 months